View this email online 

Madison Dearborn closes MoneyGram deal; Hildred Capital, HCAP and PSG bet on pharmacy services

Good morning dealmakers, thank goodness it’s Friday!

It’s Obey Martin Manayiti here with the Wire.

To cap off the week, I will look at six PE-backed pharmacy service deals targeting growth, all announced this year.

Hildred Capital co-founder Andrew Goldman shared some thoughts on deals in the sector.

Quite a few deals caught my eye this week:

– one announced this morning from Growth Catalyst Partners

– the $1.8 billion take-private of MoneyGram by Madison Dearborn Partners

– a pair of supply chain deals from KKR

Subscribers to the premium version of the Wire can find lots of details on all those transactions and more.

Integrated services

Technology is infusing pharmacies, as customers demand the same experience they have with other types of retail, like online service and home delivery. To fill the need, pharmacy services have been thriving, and private equity firms have seized on the opportunity.

PE Hub has observed a steady stream of private equity-backed pharmacy investments this year.

Subscribers will find details on six deals I rounded up here.

New York-based Hildred Capital Management, a healthcare-focused private equity firm, made a strategic investment in AleraCare, a Phoenix-headquartered provider of infusion and specialty pharmacy services.

Andrew Goldman, the firm’s co-founder and managing partner told me more about opportunities that the firm found in this sector.

Subscribe to the premium version of the Wire to read the interview.

That’s all from me.

Have a nice weekend, and MK will be back with you on Monday.

Cheers,

Obey

Read the full wire commentary on PE Hub ...

Also of note (may require subscriptions)

In a clear sign that things are tough in private equity fundraising, GPs in the first quarter logged a record amount of time on the road. (Buyouts)

It doesn’t happen that much these days, but a pension system has established its first allocation to private equity. Better late than never? (Buyouts)

Private Equity International’s global editorial team comes together to discuss how a perennial heavyweight reclaimed the top spot after sliding last year, and other results from the 2023 PEI 300 fundraising ranking.

And speaking of the PEI 300, the 2023 list is brimming with success stories. Future editions, however, are likely to reflect the dark clouds gathering over the fundraising landscape. (Private Equity International)

Under the hood of debt-for-nature swaps: The sovereign debt restructuring facility seems capable of solving numerous challenges simultaneously but has some way to go before it becomes an easily replicable way of protecting natural capital. (New Private Markets)

Hamilton Lane is nearing the $2 billion mark for its sixth flagship secondaries fund, Brian Gildea, managing director and head of evergreen portfolios, said on the firm’s full fiscal year 2023 earnings call. (Secondaries Investor)

Paris-based and sustainability-focused RAISE is taking its game to infrastructure with a new fund and a new team poached from EDF Invest. (Infrastructure Investor)

San Diego-headquartered Axos Bank, which is looking to build a subscription line lending program in the wake of the fall or rescue acquisition of three major players in the market, is building out its team. It started with the hire of Trevor Freeman, one of the founders of Signature Bank’s Fund Banking Division. (Private Funds CFO)

The legacy of BEX founder Benjamin Revillon, who passed away on Sunday after struggling with illness, spans more than just niche secondaries investing. (Secondaries Investor)

Proof VC has closed on $124 million for its third opportunity fund, according to a regulatory filing. (Venture Capital Journal)